446 related articles for article (PubMed ID: 28983775)
21. Importance of the determination of enzymatic activity in the diagnosis of deficiency of adenosine deaminase 2 (DADA2).
Abbasi A; Batllori M; Gil-Sáez FJ; Rodríguez-Pintó I; Antón López J; Iglesias Jímenez E
Med Clin (Barc); 2022 Sep; 159(6):283-286. PubMed ID: 35241284
[TBL] [Abstract][Full Text] [Related]
22. Novel compound heterozygous variants in CECR1 gene associated with childhood onset polyarteritis nodosa and deficiency of ADA2.
Keer N; Hershfield M; Caskey T; Unizony S
Rheumatology (Oxford); 2016 Jun; 55(6):1145-7. PubMed ID: 27069017
[No Abstract] [Full Text] [Related]
23. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation.
Lamprecht P; Humrich JY; Diebold I; Riemekasten G
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):177. PubMed ID: 29600946
[No Abstract] [Full Text] [Related]
25. Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases.
Nanthapisal S; Murphy C; Omoyinmi E; Hong Y; Standing A; Berg S; Ekelund M; Jolles S; Harper L; Youngstein T; Gilmour K; Klein NJ; Eleftheriou D; Brogan PA
Arthritis Rheumatol; 2016 Sep; 68(9):2314-22. PubMed ID: 27059682
[TBL] [Abstract][Full Text] [Related]
26. Atypical phenotype of an old disease or typical phenotype of a new disease: deficiency of adenosine deaminase 2.
Çakan M; Aktay-Ayaz N; Karadağ ŞG; Tahir-Turanlı E; Stafstrom K; Bainter W; Geha RS; Chou J
Turk J Pediatr; 2019; 61(3):413-417. PubMed ID: 31916720
[TBL] [Abstract][Full Text] [Related]
27. Novel Mutation in CECR1 Leads to Deficiency of ADA2 with Associated Neutropenia.
Cipe FE; Aydogmus C; Serwas NK; Keskindemirci G; Boztuğ K
J Clin Immunol; 2018 Apr; 38(3):273-277. PubMed ID: 29564582
[TBL] [Abstract][Full Text] [Related]
28. Histiocytoid Sweet Syndrome Presenting in Two Sisters With Deficiency of Deaminase Type 2.
Hui Ong EL; Cooray S; Brogan P; Calonje E
Am J Dermatopathol; 2023 Jan; 45(1):47-50. PubMed ID: 36484606
[TBL] [Abstract][Full Text] [Related]
29. Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood.
Schepp J; Proietti M; Frede N; Buchta M; Hübscher K; Rojas Restrepo J; Goldacker S; Warnatz K; Pachlopnik Schmid J; Duppenthaler A; Lougaris V; Uriarte I; Kelly S; Hershfield M; Grimbacher B
Arthritis Rheumatol; 2017 Aug; 69(8):1689-1700. PubMed ID: 28493328
[TBL] [Abstract][Full Text] [Related]
30. A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants.
Parlar K; Tahir Turanli E; Nuhoglu Kantarci E; Hacioglu A; Kirectepe Aydin A; Ayla AY; Voyvoda U; Ozdogan H; Ugurlu S
Mod Rheumatol Case Rep; 2023 Dec; 8(1):121-124. PubMed ID: 37542433
[TBL] [Abstract][Full Text] [Related]
31. Clinical presentation of children with Deficiency of Adenosine deaminase 2: A case series.
Kisla Ekinci RM; Anlas O; Ozalp O
Eur J Med Genet; 2022 Aug; 65(8):104555. PubMed ID: 35777620
[TBL] [Abstract][Full Text] [Related]
32. Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity.
Signa S; Bertoni A; Penco F; Caorsi R; Cafaro A; Cangemi G; Volpi S; Gattorno M; Schena F
Front Immunol; 2022; 13():935957. PubMed ID: 35898506
[TBL] [Abstract][Full Text] [Related]
33. The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.
Kendall JL; Springer JM
Curr Rheumatol Rep; 2020 Aug; 22(10):64. PubMed ID: 32845415
[TBL] [Abstract][Full Text] [Related]
34. Clusters in Pediatric Rheumatic Diseases.
Sag E; Demir S; Ozen S
Curr Rheumatol Rep; 2020 May; 22(7):28. PubMed ID: 32436006
[TBL] [Abstract][Full Text] [Related]
35. Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.
Hashem H; Egler R; Dalal J
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e293-e296. PubMed ID: 28230570
[TBL] [Abstract][Full Text] [Related]
36. Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.
Schnappauf O; Sampaio Moura N; Aksentijevich I; Stoffels M; Ombrello AK; Hoffmann P; Barron K; Remmers EF; Hershfield M; Kelly SJ; ; Cuthbertson D; Carette S; Chung SA; Forbess L; Khalidi NA; Koening CL; Langford CA; McAlear CA; Monach PA; Moreland L; Pagnoux C; Seo P; Springer JM; Sreih AG; Warrington KJ; Ytterberg SR; Kastner DL; Grayson PC; Merkel PA;
Arthritis Rheumatol; 2021 Mar; 73(3):512-519. PubMed ID: 33021335
[TBL] [Abstract][Full Text] [Related]
37. The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort.
Barron KS; Aksentijevich I; Deuitch NT; Stone DL; Hoffmann P; Videgar-Laird R; Soldatos A; Bergerson J; Toro C; Cudrici C; Nehrebecky M; Romeo T; Jones A; Boehm M; Kanakry JA; Dimitrova D; Calvo KR; Alao H; Kapuria D; Ben-Yakov G; Pichard DC; Hathaway L; Brofferio A; McRae E; Moura NS; Schnappauf O; Rosenzweig S; Heller T; Cowen EW; Kastner DL; Ombrello AK
Front Immunol; 2021; 12():811473. PubMed ID: 35095905
[TBL] [Abstract][Full Text] [Related]
38. A Novel Germline Mutation of
Vai S; Marin E; Cosso R; Saettini F; Bonanomi S; Cattoni A; Chiodini I; Persani L; Falchetti A
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361096
[TBL] [Abstract][Full Text] [Related]
39. Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency.
Schepp J; Bulashevska A; Mannhardt-Laakmann W; Cao H; Yang F; Seidl M; Kelly S; Hershfield M; Grimbacher B
J Clin Immunol; 2016 Apr; 36(3):179-86. PubMed ID: 26922074
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
